Dan S - Search Results

1

An integrated database of chemosensitivity to 55 anticancer drugs and gene expression profiles of 39 human cancer cell lines.

Dan S, Tsunoda T, Kitahara O, Yanagawa R, Zembutsu H, Katagiri T, Yamazaki K, Nakamura Y, Yamori T. Dan S, et al. Cancer Res. 2002 Feb 15;62(4):1139-47. Cancer Res. 2002. PMID: 11861395

2

Expression of a multidrug-resistance gene in human malignant lymphoma and related disorders.

Dan S, Esumi M, Sawada U, Hayashi N, Uchida T, Yamazaki T, Ashiya M, Satoh Y, Ohshim T, Horie T, et al. Dan S, et al. Leuk Res. 1991;15(12):1139-43. doi: 10.1016/0145-2126(91)90182-s. Leuk Res. 1991. PMID: 1766262

3

A large-scale gene expression comparison of microdissected, small-sized endometrial cancers with or without hyperplasia matched to same-patient normal tissue.

Sugiyama Y, Dan S, Yoshida Y, Akiyama F, Sugiyama K, Hirai Y, Matsuura M, Miyata S, Ushijima M, Hasumi K, Yamori T. Sugiyama Y, et al. Among authors: dan s. Clin Cancer Res. 2003 Nov 15;9(15):5589-600. Clin Cancer Res. 2003. PMID: 14654540

4

Identification of candidate predictive markers of anticancer drug sensitivity using a panel of human cancer cell lines.

Dan S, Shirakawa M, Mukai Y, Yoshida Y, Yamazaki K, Kawaguchi T, Matsuura M, Nakamura Y, Yamori T. Dan S, et al. Cancer Sci. 2003 Dec;94(12):1074-82. doi: 10.1111/j.1349-7006.2003.tb01403.x. Cancer Sci. 2003. PMID: 14662023 Free PMC article.

5

Chemosensitivity profile of cancer cell lines and identification of genes determining chemosensitivity by an integrated bioinformatical approach using cDNA arrays.

Nakatsu N, Yoshida Y, Yamazaki K, Nakamura T, Dan S, Fukui Y, Yamori T. Nakatsu N, et al. Among authors: dan s. Mol Cancer Ther. 2005 Mar;4(3):399-412. doi: 10.1158/1535-7163.MCT-04-0234. Mol Cancer Ther. 2005. PMID: 15767549

6

Absolute quantification of four isoforms of the class I phosphoinositide-3-kinase catalytic subunit by real-time RT-PCR.

Nakamura H, Dan S, Akashi T, Unno M, Yamori T. Nakamura H, et al. Among authors: dan s. Biol Pharm Bull. 2007 Jun;30(6):1181-4. doi: 10.1248/bpb.30.1181. Biol Pharm Bull. 2007. PMID: 17541179 Free article.

7

A new evaluation method for quantifying PI3K activity by HTRF assay.

Sugita H, Dan S, Kong D, Tomida A, Yamori T. Sugita H, et al. Among authors: dan s. Biochem Biophys Res Commun. 2008 Dec 19;377(3):941-5. doi: 10.1016/j.bbrc.2008.10.083. Epub 2008 Oct 24. Biochem Biophys Res Commun. 2008. PMID: 18952065

8

Inhibition of PI3K by ZSTK474 suppressed tumor growth not via apoptosis but G0/G1 arrest.

Dan S, Yoshimi H, Okamura M, Mukai Y, Yamori T. Dan S, et al. Biochem Biophys Res Commun. 2009 Jan 30;379(1):104-9. doi: 10.1016/j.bbrc.2008.12.015. Epub 2008 Dec 16. Biochem Biophys Res Commun. 2009. PMID: 19094964

9

Identification of candidate genes determining chemosensitivity to anti-cancer drugs of gastric cancer cell lines.

Nakamura T, Nakatsu N, Yoshida Y, Yamazaki K, Dan S, Sadahiro S, Makuuchi H, Yamori T. Nakamura T, et al. Among authors: dan s. Biol Pharm Bull. 2009 Nov;32(11):1936-9. doi: 10.1248/bpb.32.1936. Biol Pharm Bull. 2009. PMID: 19881313 Free article.

10

Inhibition profiles of phosphatidylinositol 3-kinase inhibitors against PI3K superfamily and human cancer cell line panel JFCR39.

Kong D, Dan S, Yamazaki K, Yamori T. Kong D, et al. Among authors: dan s. Eur J Cancer. 2010 Apr;46(6):1111-21. doi: 10.1016/j.ejca.2010.01.005. Epub 2010 Feb 1. Eur J Cancer. 2010. PMID: 20129775

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

352 results

Search Page

Filters